Spironolactone may reduce the risk of incident rosacea

J Invest Dermatol. 2013 Oct;133(10):2480-2483. doi: 10.1038/jid.2013.186. Epub 2013 Apr 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Databases, Factual
  • Diuretics / therapeutic use
  • Female
  • Humans
  • Incidence
  • Male
  • Risk Factors
  • Rosacea / epidemiology*
  • Rosacea / prevention & control*
  • Spironolactone / therapeutic use*

Substances

  • Diuretics
  • Spironolactone